![](/img/cover-not-exists.png)
PSY45 PATIENT-REPORTED OUTCOMES USED IN CLINICAL TRIALS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF SUITABILITY FOR FDA LABELLING CLAIMS
Medic, N., Zupan, Z., Brown Hajdukova, E., Rudell, K.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2672
Date:
November, 2019
File:
PDF, 389 KB
english, 2019